
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Please subscribe for latest posts and news with your email address.
Popular: Warning Letters, Recalls
The USFDA issued a notification on 22 May, 2025 on Data Integrity concerns on reliability and validity of biocompatibility testing and animal safety and performance testing studies conducted for Medical devices by third Party testing facilities. As per the notification...
Strides Pharma Inc is recalling over 38 lots of Testosterone Gel 1% in the US due to presence of benzene contaminant as per California State Board of Pharmacy Recall Alert. The benzene contaminant is resulting from one of the excipients...
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators Joseph A. Piechocki and Rafeeq
Aarti Drugs API facility in Tarapur, India was inspected by USFDA investigators Rajeev R. Srivastava and Suzanne N. Vallez in
The U.S. Food and Drug Administration (FDA) has issued a Warning Letter in June 2025 to Chinese drug manufacturer Yiling
Herbal medicines have been used for thousands of years across different cultures to treat illnesses and promote health. Derived from